Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
Brain : a Journal of Neurology|September 7, 2010
Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathyPete A Williams, James E Morgan, Marcela VotrubaClinical & Experimental Ophthalmology|July 29, 2020
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trialFlora Hui, Jessica Tang, Pete A Williams, et al.Experimental Eye Research|March 1, 2017
Neuroinflammation in glaucoma: A new opportunityPete A Williams, Nick Marsh-Armstrong, Gareth R Howell, et al.Journal of Clinical Medicine|September 10, 2021
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell NeuroprotectionTim J Enz, James R Tribble, Pete A WilliamsSurvey of Ophthalmology|September 29, 2024
Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysisGustav Stålhammar, Anna Hagström, Malin Ermedahl Conradi, et al.Frontiers in Ophthalmology|July 10, 2024
Glial metabolic alterations during glaucoma pathogenesisAnne Rombaut, Rune Brautaset, Pete A Williams, et al.BMC Cancer|April 13, 2022
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literatureAnna Hagström, Ruba Kal Omar, Pete A Williams, et al.Journal of Glaucoma|September 1, 2017
Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in GlaucomaPete A Williams, Jeffrey M Harder, Simon W M JohnMolecular Brain|November 22, 2024
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucomaAnne Rombaut, Rune Brautaset, Pete A Williams, et al.Brain Research Bulletin|June 22, 2025
Amino acid neurotransmitters in sarcopenia and healthy agingSteffi M Jonk, James R Tribble, Peter Swoboda, et al.Pageof 10